TE Connectivity acquires three life science development and manufacturing firms; expands reach into IVD, point of care and microfluidics segments

TE Connectivity, a world leader in connectors and sensors, has acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research and manufacturing. The companies are Toolbox Medical Innovations (USA), Wi Inc (USA) and microiLIQUID (Spain).

The combined entities leverage design and manufacturing capabilities in the United States and Europe and are focused on serving a global client base ranging from startups to multinationals in the life science, IVD and cell therapy markets.

SLAS Discovery’s September Special Collection “Applications of Biophysics in Early Drug Discovery” Now Available

The September edition of SLAS Discovery is a Special Collection featuring the cover article, “Applications of Biophysics in Early Drug Discovery” by Geoffrey A. Holdgate (AstraZeneca, Macclesfield, UK) and Christian Bergsdorf, Ph.D. (Novartis Institutes for Biomedical Research, Basel, Switzerland).

SLAS Discovery’s July Special Edition “Drug Discovery Targeting COVID-19” Now Available

The July edition of SLAS Discovery is a Special Edition featuring the cover article, “Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry” by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).

FDA Approves First At-Home Saliva Collection Test for Coronavirus

Rutgers’ RUCDR Infinite Biologics received an amended emergency use authorization from the FDA late Thursday for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results. The decision follows the FDA’s recent emergency approval to RUCDR Infinite Biologics for the first saliva-based test, which involves health care workers collecting saliva from individuals at testing sites.

SLAS Releases COVID-19 Infographics to Explain Research Terminology

SLAS has released the first two infographics in an ongoing series of tools to help the general public better understand the technical jargon being discussed during the COVID-19 pandemic. Official press conferences, news articles, statistical reports, social media posts and health organizations use technical research terms that often are misunderstood (or not understood at all) by a general audience.